Gray and white matter volume changes in early RRMS: a 2-year longitudinal study

Neurology. 2005 Mar 22;64(6):1001-7. doi: 10.1212/01.WNL.0000154526.22878.30.


Background: Brain atrophy, in excess of that seen with normal aging, has been observed early in the clinical course of relapsing-remitting multiple sclerosis (RRMS). Previous work has suggested that at this stage of the disease, gray matter (GM) atrophy progresses more rapidly than the white matter (WM) atrophy.

Objectives: To characterize the evolution of GM and WM volumes over 2 years, and their associations with lesion loads in a cohort of patients with clinically early RRMS.

Methods: Twenty-one patients with RRMS (mean age 37.5 years, mean disease duration from symptom onset 2.1 years) and 10 healthy control subjects (mean age 37.1 years) were studied. Tissue volumes, as fractions of total intracranial volumes, were estimated at baseline and 1- and 2-year follow-up. Brain parenchymal fractions (BPF), GM fractions (GMF), and WM fractions (WMF) were estimated. In subjects with MS, brain lesion loads were determined on conventional T2-weighted along with pre- and post-gadolinium (Gd) enhanced T1-weighted images at each timepoint.

Results: A decrease in GMF was observed in subjects with MS vs normal controls over the 2 years of the study (mean -2.1% vs -1.0%, p = 0.044), while no change was seen in WMF over the same period (mean -0.09% vs +0.09%, p = 0.812). However, when the MS cohort was divided in half, dependent upon change in Gd-enhancing lesion load over 2 years (n = 20), a decrease in WMF was seen in the group (n = 10) with the largest decline in Gd volume, whereas WMF increased in the other half (n = 10) concurrent with a net increase in volume of Gd-enhancing lesions (difference between groups: p = 0.034).

Conclusions: Increasing gray matter but not white matter (WM) atrophy was observed early in the clinical course of relapsing-remitting multiple sclerosis. Fluctuations in inflammatory WM lesions appear to be related to volume changes in WM over this time period.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atrophy / diagnosis
  • Atrophy / etiology
  • Atrophy / physiopathology
  • Central Nervous System / pathology*
  • Central Nervous System / physiopathology
  • Cohort Studies
  • Cross-Sectional Studies
  • Disease Progression
  • Early Diagnosis
  • Encephalitis / diagnosis
  • Encephalitis / physiopathology
  • Female
  • Humans
  • Longitudinal Studies
  • Magnetic Resonance Imaging / standards*
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology
  • Myelitis / diagnosis
  • Myelitis / physiopathology
  • Nerve Fibers, Myelinated / pathology*
  • Neural Pathways / pathology
  • Neural Pathways / physiopathology
  • Predictive Value of Tests
  • Time Factors